Aprotinin reduces operative closure time and blood product use after pediatric bypass
Authors:
- Carl L BackerCBCarl L Backer
- Alberto de HoyosAHAlberto de Hoyos
- Helen J BinnsHBHelen J Binns
- Constantine MavroudisCMConstantine Mavroudis
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (4) , 1261-1266
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Activation of the kallikrein-kinin system by cardiopulmonary bypass in humansAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in childrenThe Annals of Thoracic Surgery, 2000
- Pro: The routine use of aprotinin during pediatric cardiac surgery is a benefitJournal of Cardiothoracic and Vascular Anesthesia, 1999
- Con: The routine use of aprotinin during pediatric cardiac surgery is not a benefitJournal of Cardiothoracic and Vascular Anesthesia, 1999
- Complement Activation and Cytokine Generation After Modified Fontan ProcedureThe Annals of Thoracic Surgery, 1998
- Cardiopulmonary bypass and the inflammatory response: A role for serine protease inhibitors?Journal of Cardiothoracic and Vascular Anesthesia, 1997
- A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass GraftingCirculation, 1995
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Book reviews : Reid CC, Kurusz M, Lawrence AE: Safety and techniques in perfusion. Stafford, Texas: Quali- Med Inc. 264pp; 36 illPerfusion, 1990
- Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgeryJournal of Cardiothoracic Anesthesia, 1989